Detalles de la búsqueda
1.
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.
Virol J
; 20(1): 154, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37464440
2.
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years.
BMC Infect Dis
; 23(1): 118, 2023 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36829111
3.
The Effects of Curcumin Administration on Carotid Intima-Media Thickness and Pulse Wave Velocity in Diabetic Hemodialysis Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Int J Prev Med
; 15: 3, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38487702
4.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial.
Vaccine X
; 15: 100401, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941802
5.
Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.
Vaccines (Basel)
; 10(11)2022 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366308
6.
Overexpression of protein kinase Mζ in the hippocampus mitigates Alzheimer's disease-related cognitive deficit in rats.
Brain Res Bull
; 166: 64-72, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188852
7.
Development of Inactivated FAKHRAVAC® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models.
Vaccines (Basel)
; 9(11)2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34835202
Resultados
1 -
7
de 7
1
Próxima >
>>